Home \ Neurology \ The effectiveness of Mexidol® in cognitive impairment: decreased memory, attention, and performance

The effectiveness of Mexidol® for cognitive disorders: decrease in memory, attention, performance

The brain in focus of arterial hypertension

Peculiarities of managing elderly patients

The brain is a key target organ for treatment of cerebrovascular risks

Mexidol as a geroprotector: potential and prospects

Neuroprotection in arterial hypertension and cognitive impairment

The Connection Between Vascular Diseases of the Brain and Eye: A Neurologist and Ophthalmologist's Perspective

Ischemic stroke: clinical guidelines and practical aspects

NIHSS and mRS: Gold Standards in Neuroscience

Cognitive impairment caused by arterial hypertension: from clinical guidelines to practical algorithms

The brain is a target organ for arterial hypertension: features of management of the elderly patient

Time codes:

00:00
The main symptom of chronic brain ischemia
00:45
Mini-Cog test methodology to check cognitive function

Vladimir Vladimirovich Zakharov – Doctor of Medical Sciences, Professor of the Department of Nervous System Diseases of the Faculty of Medicine of the First Moscow State Medical University named after I.M. Sechenov

Announcement:

It has now been proven that cognitive impairment is the main symptom of chronic cerebral ischemia. This symptom is crucial for both the physician and the patient. For the patient, it is cognitive impairment that impairs quality of life, and for the physician, it is the primary diagnostic criterion. Mexidol® is often recommended as a pathogenetic therapy. Mexidol® has an anti-amnestic effect on memory and attention and has a pronounced ability to improve higher nervous system processes. Its effectiveness has been proven for cerebral ischemia, cognitive impairment, anxiety disorders, and other disorders.

All videos Next video

The brain in focus of arterial hypertension

Peculiarities of managing elderly patients

The brain is a key target organ for treatment of cerebrovascular risks

Mexidol as a geroprotector: potential and prospects

Neuroprotection in arterial hypertension and cognitive impairment

The Connection Between Vascular Diseases of the Brain and Eye: A Neurologist and Ophthalmologist's Perspective

Ischemic stroke: clinical guidelines and practical aspects

NIHSS and mRS: Gold Standards in Neuroscience

Cognitive impairment caused by arterial hypertension: from clinical guidelines to practical algorithms

The brain is a target organ for arterial hypertension: features of management of the elderly patient

Time codes:

00:00
The main symptom of chronic brain ischemia
00:45
Mini-Cog test methodology to check cognitive function

Block of articles on this topic

Cognitive disorders diagnostic algorithm in outpatient practice

Authors:
E.A. MKHITARYAN, M.A. ATTIC

Arterial hypertension and cognitive disorders. The gaze of a neurologist

Author:
A.I. FEDIN

FGAOU in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia

Features of pharmacotherapy of vascular cognitive impairment in elderly people

Author:
A.N. BOGOLEPOVA^1,²

¹N.I. Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation, Moscow, Russia;
²Federal Center for Brain and Neurotechnology of the Federal Medical and Biological Agency of Russia, Moscow, Russia

Cognitive disorders in the practice of a primary link: Focus for patients with arterial hypertension

Authors:
O.D. OSTROUMOVA, A.I. KOCHETKOV, N.A. SHATALOVA

Approaches to pharmacotherapy of vascular moderate cognitive disorders in patients of various age groups

Authors:
V.V. ZAKHAROV¹, A.I. FEDIN², E.A. MKHITARYAN^2,³

THE INFORMATION IS INTENDED FOR HEALTHCARE AND PHARMACEUTICAL PROFESSIONALS. THIS INFORMATION IS NOT INTENDED AS A SUBSTITUTE FOR MEDICAL ADVICE.

Source of photos and images Shutterstock.com